세계의 누트로픽(Nootropics) 시장 규모, 점유율, 동향 분석 보고서 : 유통 채널별, 형태별, 지역별 전망 및 예측(2025-2032년)

The Global Nootropics Market size is expected to reach $13.31 billion by 2032, rising at a market growth of 14.3% CAGR during the forecast period.

The North America segment recorded 40% revenue share in the market in 2024. The strong market presence in this region can be attributed to the growing consumer awareness regarding cognitive enhancers, the widespread availability of nootropic products, and the well-established health and wellness industry. Additionally, the increasing adoption of dietary supplements among working professionals, students, and older adults further propelled the demand for nootropics.

As awareness around cognitive health and mental performance grows, individuals increasingly seek ways to enhance their mental abilities, memory, focus, and overall brain health. This awareness is being fuelled by a combination of factors, including the rise of social media, increased scientific research, and the increasing importance placed on mental wellness. The modern lifestyle, filled with multitasking, high stress, and a constant demand for peak performance, has led many to recognize the significance of maintaining cognitive sharpness. Thus, increasing awareness about cognitive health and mental performance enhancement drives the market's growth.

Additionally, In recent years, there has been a significant shift toward preventive healthcare, as individuals prioritize long-term wellness rather than solely focusing on treating illnesses once they arise. This shift is driven by a growing desire to take control of one's health, and people are increasingly incorporating supplements and wellness products into their daily routines. Nootropics fit perfectly into this movement, offering a proactive approach to maintaining brain health, boosting mental performance, and enhancing overall well-being. Therefore, as such, the growing adoption of preventive healthcare practices is undoubtedly fuelling the demand for nootropics, further embedding them into the wellness routines of consumers worldwide.

However, One of the significant barriers hindering the widespread adoption of nootropics is the high cost associated with premium or prescription-based formulations. While nootropics offer cognitive enhancement benefits, the high price tag of certain products limits their accessibility to a larger portion of the population. Premium nootropic formulations, which often include a combination of expensive ingredients or proprietary blends, can be cost-prohibitive for many individuals, particularly those in lower income brackets or developing regions. Thus, the high cost of premium or prescription-based nootropic formulations restricting accessibility is impeding the growth of the market.

Distribution Channel Outlook

On the basis of distribution channel, the market is classified into offline and online. The online segment recorded 28% revenue share in the market in 2024. This segment's growth was fuelled by increasing internet penetration, rising smartphone usage, and the convenience of home delivery. Consumers increasingly turned to e-commerce platforms for a wide variety of nootropic products, attracted by competitive pricing, product reviews, and access to global brands. The growth of digital marketing strategies and influencer-driven promotions also played a vital role in enhancing visibility and boosting online sales in this segment.

Form Outlook

Based on form, the market is characterized into capsules/tablets, powder, drinks, and others. The powder segment procured 25% revenue share in the market in 2024. This form gained traction among fitness enthusiasts, students, and health-conscious individuals who preferred customizable dosages and quick absorption. Powders are often used in smoothies or health drinks, allowing users to integrate nootropics into their daily routines easily. The increasing demand for personalized nutrition and the availability of flavoured and unflavoured powder options contributed significantly to the growth of this segment.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific segment witnessed 26% revenue share in the market in 2024. This growth was driven by rising health consciousness, increasing urbanization, and a growing focus on mental well-being across countries like China, India, Japan, and South Korea. The region has witnessed a surge in demand for brain health supplements, especially among young adults and students.

List of Key Companies Profiled

• Onnit Labs, Inc.
• Reckitt Benckiser Group PLC
• Natural Stacks
• Mind Lab Pro (Opti-Nutra, ltd.)
• PowderCity.com,Ltd
• NOW Foods, Inc.
• Purelife Bioscience Co., Ltd.
• Peak Nootropics
• AlternaScript
• Teva Pharmaceutical Industries Ltd.

Global Nootropics Market Report Segmentation

By Distribution Channel

• Offline
• Online

By Form

• Capsules & Tablets
• Powder
• Drinks
• Other Form

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Nootropics Market, by Distribution Channel
  • 1.4.2 Global Nootropics Market, by Form
  • 1.4.3 Global Nootropics Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
  • 3.2.3 Market Opportunities
  • 3.2.4 Market Challenges
• 3.3 Porter Five Forces Analysis

Chapter 4. Global Nootropics Market by Distribution Channel

• 4.1 Global Offline Market by Region
• 4.2 Global Online Market by Region

Chapter 5. Global Nootropics Market by Form

• 5.1 Global Capsules & Tablets Market by Region
• 5.2 Global Powder Market by Region
• 5.3 Global Drinks Market by Region
• 5.4 Global Other Form Market by Region

Chapter 6. Global Nootropics Market by Region

• 6.1 North America Nootropics Market
  • 6.1.1 North America Nootropics Market by Distribution Channel
    • 6.1.1.1 North America Offline Market by Region
    • 6.1.1.2 North America Online Market by Region
  • 6.1.2 North America Nootropics Market by Form
    • 6.1.2.1 North America Capsules & Tablets Market by Country
    • 6.1.2.2 North America Powder Market by Country
    • 6.1.2.3 North America Drinks Market by Country
    • 6.1.2.4 North America Other Form Market by Country
  • 6.1.3 North America Nootropics Market by Country
    • 6.1.3.1 US Nootropics Market
      • 6.1.3.1.1 US Nootropics Market by Distribution Channel
      • 6.1.3.1.2 US Nootropics Market by Form
    • 6.1.3.2 Canada Nootropics Market
      • 6.1.3.2.1 Canada Nootropics Market by Distribution Channel
      • 6.1.3.2.2 Canada Nootropics Market by Form
    • 6.1.3.3 Mexico Nootropics Market
      • 6.1.3.3.1 Mexico Nootropics Market by Distribution Channel
      • 6.1.3.3.2 Mexico Nootropics Market by Form
    • 6.1.3.4 Rest of North America Nootropics Market
      • 6.1.3.4.1 Rest of North America Nootropics Market by Distribution Channel
      • 6.1.3.4.2 Rest of North America Nootropics Market by Form
• 6.2 Europe Nootropics Market
  • 6.2.1 Europe Nootropics Market by Distribution Channel
    • 6.2.1.1 Europe Offline Market by Country
    • 6.2.1.2 Europe Online Market by Country
  • 6.2.2 Europe Nootropics Market by Form
    • 6.2.2.1 Europe Capsules & Tablets Market by Country
    • 6.2.2.2 Europe Powder Market by Country
    • 6.2.2.3 Europe Drinks Market by Country
    • 6.2.2.4 Europe Other Form Market by Country
  • 6.2.3 Europe Nootropics Market by Country
    • 6.2.3.1 Germany Nootropics Market
      • 6.2.3.1.1 Germany Nootropics Market by Distribution Channel
      • 6.2.3.1.2 Germany Nootropics Market by Form
    • 6.2.3.2 UK Nootropics Market
      • 6.2.3.2.1 UK Nootropics Market by Distribution Channel
      • 6.2.3.2.2 UK Nootropics Market by Form
    • 6.2.3.3 France Nootropics Market
      • 6.2.3.3.1 France Nootropics Market by Distribution Channel
      • 6.2.3.3.2 France Nootropics Market by Form
    • 6.2.3.4 Russia Nootropics Market
      • 6.2.3.4.1 Russia Nootropics Market by Distribution Channel
      • 6.2.3.4.2 Russia Nootropics Market by Form
    • 6.2.3.5 Spain Nootropics Market
      • 6.2.3.5.1 Spain Nootropics Market by Distribution Channel
      • 6.2.3.5.2 Spain Nootropics Market by Form
    • 6.2.3.6 Italy Nootropics Market
      • 6.2.3.6.1 Italy Nootropics Market by Distribution Channel
      • 6.2.3.6.2 Italy Nootropics Market by Form
    • 6.2.3.7 Rest of Europe Nootropics Market
      • 6.2.3.7.1 Rest of Europe Nootropics Market by Distribution Channel
      • 6.2.3.7.2 Rest of Europe Nootropics Market by Form
• 6.3 Asia Pacific Nootropics Market
  • 6.3.1 Asia Pacific Nootropics Market by Distribution Channel
    • 6.3.1.1 Asia Pacific Offline Market by Country
    • 6.3.1.2 Asia Pacific Online Market by Country
  • 6.3.2 Asia Pacific Nootropics Market by Form
    • 6.3.2.1 Asia Pacific Capsules & Tablets Market by Country
    • 6.3.2.2 Asia Pacific Powder Market by Country
    • 6.3.2.3 Asia Pacific Drinks Market by Country
    • 6.3.2.4 Asia Pacific Other Form Market by Country
  • 6.3.3 Asia Pacific Nootropics Market by Country
    • 6.3.3.1 China Nootropics Market
      • 6.3.3.1.1 China Nootropics Market by Distribution Channel
      • 6.3.3.1.2 China Nootropics Market by Form
    • 6.3.3.2 Japan Nootropics Market
      • 6.3.3.2.1 Japan Nootropics Market by Distribution Channel
      • 6.3.3.2.2 Japan Nootropics Market by Form
    • 6.3.3.3 India Nootropics Market
      • 6.3.3.3.1 India Nootropics Market by Distribution Channel
      • 6.3.3.3.2 India Nootropics Market by Form
    • 6.3.3.4 South Korea Nootropics Market
      • 6.3.3.4.1 South Korea Nootropics Market by Distribution Channel
      • 6.3.3.4.2 South Korea Nootropics Market by Form
    • 6.3.3.5 Singapore Nootropics Market
      • 6.3.3.5.1 Singapore Nootropics Market by Distribution Channel
      • 6.3.3.5.2 Singapore Nootropics Market by Form
    • 6.3.3.6 Malaysia Nootropics Market
      • 6.3.3.6.1 Malaysia Nootropics Market by Distribution Channel
      • 6.3.3.6.2 Malaysia Nootropics Market by Form
    • 6.3.3.7 Rest of Asia Pacific Nootropics Market
      • 6.3.3.7.1 Rest of Asia Pacific Nootropics Market by Distribution Channel
      • 6.3.3.7.2 Rest of Asia Pacific Nootropics Market by Form
• 6.4 LAMEA Nootropics Market
  • 6.4.1 LAMEA Nootropics Market by Distribution Channel
    • 6.4.1.1 LAMEA Offline Market by Country
    • 6.4.1.2 LAMEA Online Market by Country
  • 6.4.2 LAMEA Nootropics Market by Form
    • 6.4.2.1 LAMEA Capsules & Tablets Market by Country
    • 6.4.2.2 LAMEA Powder Market by Country
    • 6.4.2.3 LAMEA Drinks Market by Country
    • 6.4.2.4 LAMEA Other Form Market by Country
  • 6.4.3 LAMEA Nootropics Market by Country
    • 6.4.3.1 Brazil Nootropics Market
      • 6.4.3.1.1 Brazil Nootropics Market by Distribution Channel
      • 6.4.3.1.2 Brazil Nootropics Market by Form
    • 6.4.3.2 Argentina Nootropics Market
      • 6.4.3.2.1 Argentina Nootropics Market by Distribution Channel
      • 6.4.3.2.2 Argentina Nootropics Market by Form
    • 6.4.3.3 UAE Nootropics Market
      • 6.4.3.3.1 UAE Nootropics Market by Distribution Channel
      • 6.4.3.3.2 UAE Nootropics Market by Form
    • 6.4.3.4 Saudi Arabia Nootropics Market
      • 6.4.3.4.1 Saudi Arabia Nootropics Market by Distribution Channel
      • 6.4.3.4.2 Saudi Arabia Nootropics Market by Form
    • 6.4.3.5 South Africa Nootropics Market
      • 6.4.3.5.1 South Africa Nootropics Market by Distribution Channel
      • 6.4.3.5.2 South Africa Nootropics Market by Form
    • 6.4.3.6 Nigeria Nootropics Market
      • 6.4.3.6.1 Nigeria Nootropics Market by Distribution Channel
      • 6.4.3.6.2 Nigeria Nootropics Market by Form
    • 6.4.3.7 Rest of LAMEA Nootropics Market
      • 6.4.3.7.1 Rest of LAMEA Nootropics Market by Distribution Channel
      • 6.4.3.7.2 Rest of LAMEA Nootropics Market by Form

Chapter 7. Company Profiles

• 7.1 Onnit Labs, Inc.
  • 7.1.1 Company Overview
• 7.2 Reckitt Benckiser Group PLC
  • 7.2.1 Company Overview
  • 7.2.2 Financial Analysis
  • 7.2.3 Segmental and Regional Analysis
  • 7.2.4 Research & Development Expenses
  • 7.2.5 SWOT Analysis
• 7.3 Natural Stacks
  • 7.3.1 Company Overview
• 7.4 Mind Lab Pro (Opti-Nutra, ltd.)
  • 7.4.1 Company Overview
• 7.5 PowderCity.com,Ltd
  • 7.5.1 Company Overview
• 7.6 NOW Foods, Inc.
  • 7.6.1 Company Overview
  • 7.6.2 SWOT Analysis
• 7.7 Purelife Bioscience Co., Ltd.
  • 7.7.1 Company Overview
• 7.8 Peak Nootropics
  • 7.8.1 Company Overview
• 7.9 AlternaScript
  • 7.9.1 Company Overview
• 7.10. Teva Pharmaceutical Industries Ltd.
  • 7.10.1 Company Overview
  • 7.10.2 Financial Analysis
  • 7.10.3 Segmental Analysis
  • 7.10.4 Research & Development Expenses
  • 7.10.5 SWOT Analysis

Chapter 8. Winning Imperatives of Nootropics Market